131 I treatment of thyroid papillary carcinoma in a patient with renal failure | Zendy

Morrish Donald W. | Zendy; Filipow Larry J. | Zendy; McEwan Alexander J. | Zendy; Schmidt Ronald | Zendy; Murland Keith R. | Zendy; Westarp Christian Von | Zendy; Betcher Kelvin B. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

131 I treatment of thyroid papillary carcinoma in a patient with renal failure

Author(s) -

Morrish Donald W.,

Filipow Larry J.,

McEwan Alexander J.,

Schmidt Ronald,

Murland Keith R.,

Westarp Christian Von,

Betcher Kelvin B.

Publication year - 1990

Publication title -

cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.052

H-Index - 304

eISSN - 1097-0142

pISSN - 0008-543X

DOI - 10.1002/1097-0142(19901215)66:12<2509::aid-cncr2820661211>3.0.co;2-m

Subject(s) - medicine , dialysis , urology , ablation , renal function , thyroid carcinoma , thyroid , surgery

Procedures for 131 I ablation in renal failure are not known. in one patient receiving dialysis, detailed dosimetry and health safety aspects were obtained. the results showed insignificant contamination of equipment, but a surprisingly significant reduction in biologic half‐life of 131 I due to efficient dialysis extraction. the data indicate that 131 I ablation can be done safely and easily during dialysis but that much higher 131 I doses must be used to achieve equivalent results to those obtained in patients with normal renal function.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research